Author:
Dange Y. D.,Salunkhe V. R.,Bhinge S. D.,Bhutkar B. R.,Momin Y. H.,
Abstract
A simple, rapid, accurate, economic and precise UV/VIS method has been developed and validated. Choice of a common solvent were essential so various solvent ranges including methanol, ethanol, acetonitrile and phosphate buffer and various concentrations ranges of various buffers were analyzed. methanol was selected as a solvent for the proposed method. Palbociclib and letrozole showed maximum absorbance at 220 and 240 nm respectively. Both drugs obey Beer Lambert’s law in the concentration range of 2-10 μg mL-1 for palbociclib and letrozole respectively. The LOD and LOQ were found to be 0.0782 μg mL-1and 0.2142μg mL-1for palbociclib, respectively. For Letrozole, the LOD and LOQ values were found to be 0.0585 μg mL-1and 1.6510μg mL-1 respectively. The method was quantitatively evaluated in terms of linearity, precision, precision, LOD, LOQ and recovery. The method is simple, convenient and suitable for the analysis of palbociclib and letrozole in bulk drug.
Publisher
Indian Drug Manufacturers' Association (IDMA)
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology
Reference24 articles.
1. 1. Pal T.K. and Ghosal S.K.: Development and validation of RP-HPLC method to determine letrozole in different pharmaceutical formulations and its application to studies of drug release from nanoparticles, Acta Polon. Pharmaceutica Drug Res., 2009, 66 1-17.
2. 2. Finn R.S., Dering J., Conklin D., Kalous O., Cohen D.J., Desai A.J., Ginther C. and Atefi, M.: A selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro, Breast Can. Res., 2009, PD 0332991; BCR 11: R77.
3. 3. Rocca A., Farolfi A., Bravaccini S., Schirone A. and Amadori D.: Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer, Expert Opin. Pharmacother, 2014, 15 407–420.
4. 4. http://ww5.komen.org/BreastCancer/RecommendedTreatmentsforMetastaticBreastCancer.html
5. 5. Xingling M.A., Lei L., Na C., Qiaogen Z., Kaihe X. and Pingkai O.: Isolation and Structural Elucidation of Palbociclib's Eight Process-Related Impurities: Two Identified as New Compounds, J. of AOAC International, 2016, 99 638-648.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献